Europe Lipidomics Equipment Market

The Europe lipidomics equipment market is expected to grow from US$ 301.13 million in 2022 to US$ 692.03 million by 2028. It is estimated to register a CAGR of 14.9% from 2022 to 2028.      

Growing Applications of Lipidomics in Biomedical Sciences is Fueling the Europe Lipidomics Equipment Market

Lipidomics, an emerging discipline of biomedical sciences, involves the characterization of complex lipidomes. It is a quantitative and complete depiction of a set of lipid species present in an organism. The lipidome characterization is based on a system-level quantitation and the detection of several networks & pathways of cellular lipids, along with their interaction with other moieties and proteins. Determining lipid profiles and comparing the profiles obtained for two physiologically linked conditions can help understand lipid metabolism pathways, which further can be employed to develop diagnostic methods for cancer, cardiovascular disorders, eye diseases, and other diseases. In March 2022, Lipotype GmbH, Lund University, and the Twincore Centre for Experimental and Clinical Infection Research demonstrated that the measurement of lipids in the blood could be used for predicting the risk of type 2 diabetes and cardiovascular disorders. Researchers from this group believe lipidome analysis is likely to emerge as a faster and cheaper method for diagnosing these diseases compared to traditional assays. Lipidomics plays a pivotal role in pharmacological research, especially in new drug discovery and development processes. It is also applied for toxicity evaluation, molecule screening, preclinical testing, etc. For example, de novo lipogenesis inhibitors are of major interest among researchers due to their pro-apoptotic effects on cancerous tissues. Lipidomics can also be used to screen such anticancer drug candidates for their ability to inhibit de novo lipid synthesis and for identifying novel drug efficacy biomarkers. Thus, a wide range of applications of lipidomics in biomedical sciences boosts the demand for lipidomics equipment, thereby propelling the Europe lipidomics equipment market.

Europe Lipidomics Equipment Market Overview

The Europe lipidomics equipment market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany held a prime share in Europe as it has the largest medical research industry in the region, the third largest in the world. The country is expected to dominate the medical research industry during the forecast period. Besides, Germany has witnessed an enormous rise in the prevalence of cancer in the past few years. For instance, according to Global Cancer Observatory, in 2020, a total of 628,519 new cases in both sexes and all ages were found, along with 69,697 (11.1%) cases of breast cancer, 67,959 (10.8%) cases of prostate cancer, 64,804 (10.3%) cases of lung cancer, 57,528 (9.2%) cases of colorectum cancer, 35,147 (5.6%) cases of bladder cancer, and 333,384 (53%) of other cancers. Lipidomics equipment help in the early diagnosis of cancer. Thus, the demand for lipidomics equipment is increasing rapidly in the country.

The German Society of Mass Spectrometry (DGMS) was founded in 1997 as a successor to the mass spectrometry working group (AGMS) to support mass spectrometry as a high-precision examination method for isolated molecules to enable and improve the exchange of experience among the members. It has more than 700 members from industry research facilities, universities, and government laboratories. The organization organizes conferences and workshops to provide training and hands-on experience with spectrometers. For instance, in 2018, DGMS organized a joint conference on mass spectroscopy and its applications. It will increase the knowledge among professionals and students, ultimately leading to higher adoption of lipidomics equipment during the forecast period.

Europe Lipidomics Equipment Market Revenue and Forecast to 2028 (US$ Million)

Europe Lipidomics Equipment Strategic Insights

Strategic insights for the Europe Lipidomics Equipment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Lipidomics Equipment Report Scope

Europe Lipidomics Equipment Regional Insights

The geographic scope of the Europe Lipidomics Equipment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Europe Lipidomics Equipment Market Segmentation  

The Europe lipidomics equipment market is segmented based on type, offerings, services, end user, and country.

Based on type, the Europe lipidomics equipment market is bifurcated into targeted and untargeted. The targeted segment held a larger market share in 2022.

Based on offerings, the Europe lipidomics equipment market is segmented into MS-based lipidomics techniques, assays for lipid metabolism, lipid flux using heavy isotope-labeled precursors, software & services, and others. The MS-based lipidomics techniques segment held the largest market share in 2022. The MS-based lipidomics techniques segment is further categorized into mass spectrometers equipped with ion sources (turbo-) ESI/nano-ESI/APCI, autosamplers, micropumps, UV detectors, UPLC, variable-length fluorescence detectors, and others.  

Based on services, the Europe lipidomics equipment market has been segmented into biomarker identification, bioinformatic analysis & data interpretation, molecular analysis of a broad spectrum of phospholipids (lipid fingerprinting), analysis & identification of unusual lipids, semiquantitative & quantitative analysis, lipid flux studies, and others. The biomarker identification segment held the largest market share in 2022.

Based on end user, the Europe lipidomics equipment market is segmented into molecular research, cellular research, clinical research, tissue & organ research, data research, organism research, technical services & prototyping, production, and others. The molecular research segment held the largest market share in 2022.    

Based on country, the Europe lipidomics equipment market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that the Rest of Europe dominated the market in 2022.     

Agilent Technologies, Inc.; Bruker; Cayman Chemical; Creative Proteomics; IonBench; Metabolon, Inc.; PerkinElmer Inc.; Sciex; Shimadzu Corporation.; and Thermo Fisher Scientific Inc. are among the leading companies operating in the Europe lipidomics equipment market.